Such data highlights the importance of variations in the melatonergic pathway in the tumor microenvironment, given that NAS, via TrkB activation, is associated with the proliferation and survival of cancer cells and cancer stem-like cells, whereas exogenous melatonin leads to the apoptosis of almost every cancer cell to which it has been applied [28]. Here, NTRK2 is linked to neoplasm.